Skip to main content
Signal8

SING GEORGE L

SEC insider (Form 3/4/5 filer). CIK 0001225471. Director at REGENERON PHARMACEUTICALS, INC. (REGN). 7 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in TARRYTOWN, NY.

Companies SING GEORGE L has filed insider reports for

  • REGENERON PHARMACEUTICALS, INC. (REGN): Director
SING GEORGE L profile photo

SING GEORGE L

CIK: 0001225471

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)3 (42.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

REGENERON PHARMACEUTICALS, INC. logo
REGN

REGENERON PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Jan 2, 2026
    Award
    Direct
    155 shares-
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Dec 30, 2025
    Tax Payment
    Direct
    6.2K shares at avg. $774.03$4.8M
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Dec 30, 2025
    Exercise
    Direct
    9.2K shares at avg. $520.01$4.8M
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Jan 2, 2025
    Award
    Direct
    166 shares-
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Dec 31, 2024
    Exercise
    Direct
    3.3K shares at avg. $413.33$1.4M
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Dec 31, 2024
    Tax Payment
    Direct
    1.9K shares at avg. $708.19$1.4M
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Sep 4, 2024
    Gift
    Direct
    1.2K shares-

1-7 of 7